12^th World Hematologists Congress March 15-16, 2018 London, UK (Park Inn by Radisson Hotel & Conference Centre London Heathrow Bath Road)

Prof. Dr Jan Jacques Michiels Multidisciplinary Internist Blood Coagulation & Vascular Medicine Center, CEO and Founder of Goodheart Institute in Nature Medicine & Health, Founder and Editor in Chief World Journal of Vascular Medicine: WJVM, Editor in chief Journal of Hematology and Thromboembolic Diseases, Editor of World Journal of Hematology: WJH. Senior Scientific Advisor European Leukemia-Net MPN, Mannheim, European Community, Brussels, Visiting professor Blood & Coagulation Disorders Depts of Hematology of the University Hospital Antwerp, Belgium, University Brno, Czech Republic and Colentina University Hospital, Bucharest, Romania. Prof. Dr Jan Jacques Michiels is Consultant Professor Blood coagulation and Co-Founder of the Hemostasis Research Unit and Von Willebrand Research Laboratory, University Hospital Antwerp, Belgium. Founder International Collaboration and Research in MPN: ICAR; MPN within the European Leukemia-Network: ELN. He is a CoFounder of the Central European Vascular. He is Expert member Leukemia Net, Mannheim, Germany (Chair & Founder ELN, Professor Hehlmann, Mannheim). Founder International Collaborations & Academic Research on Von Willebranf Factor and Von Willebrand Disease: ICAR:VWF-VDW. Prof. Dr Jan Jacques Michiels served as Guest Editor of many of the International Journals in Hematology, Hemostasis, Thrombosis and Vascular Medicine.

Leukemia, Hematology and Thromboembolic Diseases, Haemostasis, Bool & Coagulation Disorders.

Prof. Dr Jan Jacques Michiels Multidisciplinary Internist Blood Coagulation & Vascular Medicine Center, CEO and Founder of Goodheart Institute in Nature Medicine & Health, Founder and Editor in Chief World Journal of Vascular Medicine: WJVM, Editor in chief Journal of Hematology and Thromboembolic Diseases, Editor of World Journal of Hematology: WJH. Senior Scientific Advisor European Leukemia-Net MPN, Mannheim, European Community, Brussels, Visiting professor Blood & Coagulation Disorders Depts of Hematology of the University Hospital Antwerp, Belgium, University Brno, Czech Republic and Colentina University Hospital, Bucharest, Romania. Prof. Dr Jan Jacques Michiels is Consultant Professor Blood coagulation and Co-Founder of the Hemostasis Research Unit and Von Willebrand Research Laboratory, University Hospital Antwerp, Belgium. Founder International Collaboration and Research in MPN: ICAR; MPN within the European Leukemia-Network: ELN. He is a CoFounder of the Central European Vascular. He is Expert member Leukemia Net, Mannheim, Germany (Chair & Founder ELN, Professor Hehlmann, Mannheim). Founder International Collaborations & Academic Research on Von Willebranf Factor and Von Willebrand Disease: ICAR:VWF-VDW. Prof. Dr Jan Jacques Michiels served as Guest Editor of many of the International Journals in Hematology, Hemostasis, Thrombosis and Vascular Medicine.

Leukemia, Hematology and Thromboembolic Diseases, Haemostasis, Bool & Coagulation Disorders.

Dr. C.D. Atreya, Ph.D. is the Associate Director for research, Office of Blood Research and Review, Center for Biologics Research and Review at the U.S. Food and Drug Administration, USA. He has published more than 70 scientific publications in peer-reviewed journals and also serves on the editorial board for scientific journals of repute.

Hematology, Cellular Hematology

Olivier Hermine received his MD in 1992, held a post doctoral position at the university of Chicago (1987-1990) and his PhD in 1995, and is Professor of Hematology since 1999 at Paris Descartes University, Paris, France, and holds a number of positions at the Hôpital universitaire Necker-Enfants malades, also in Paris, including Director of the Department of Adult Haematology, member of the scientific and executive board of the Institute of Genetic Diseases (Imagine), Coordinator and Founder of the National Reference Centre for Mastocytosis (CEREMAST), and Director of the CNRS ERL 8254/ Paris Descartes University/INSERM U1163 research unit “Cellular and molecular basis of haematological disorders :Therapeutic implications” at the Imagine institute. Professor Hermine is Founder and Coordinator of the Laboratory of Excellence on Red Cells (GR-ex), which has been granted by the French Ministry of Research. Since 2015, he is director of the scientific committee of the National transfusion institute (INTS). He co-founded and is director of the scientific committee of the biotechnologies AB science specialized in tyrosine kinases development and Inatherys specialized in the development of antibodies against IgA receptors including transferin receptor. His topics of basic science and clinical research cover erythropoiesis regulation and erythroid disorders, immune regulation, mast cell and mastocytosis, viral lymphomagenesis, and leukaemogenesis. As an active member of both the Lymphoma Study Association (LYSA) and the European Mantle Cell Lymphoma Network (EMCL), the European Bone marrow transplantation (EBMT), the European Network on mastocytosis, and international retrovirology study group, Professor Hermine is also particularly involved in clinical and translational studies on mantle cell lymphoma, mastocytosis and virus-related lymphoma. He is the author or co-author of more than 590 publications in peer-reviewed journals, including Nature, Nature Medicine, Nature Immunology, the Journal of Experimental Medicine, the New England Journal of Medicine, Lancet Oncology, the Journal of Clinical Oncology, and Blood.

Hematology, Erythropoiesis regulation, Erythroid disorders, Immune regulation, mast cell and mastocytosis

Dr Husein Salem is a Molecular Biologist, gained his PhD in Molecular Medicine from the University of Manchester and has a research focus on novel gene and cellular therapies in hematological, cardiac and neurological disorders. Dr Victoria Robertson gained her PhD in cellular immunotherapy from the University of Edinburgh. The focus of her research was on allogeneic Epstein-Barr Virus (EBV)-specific cytotoxic T-cell (CTL) therapy for the treatment of EBV-induced post-transplant lymphoproliferative disease (PTLD).

Hematology, Molecular biology, Cardiology

Dr. Soad K. Al Jaouni is a Professor & Consultant of Hematology and Professor/Consultant of Pediatric Hematology/Oncology, Senior Researcher at Hematology Department, Faculty of Medicine, King Abdulaziz University Hospital a tertiary care medical center, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia. November 1989 had a certificate of The Royal College of Physician and Surgeon of Canada. Specialty Hematology, Toronto University, Canada. February 1990 and March 2006 had a Fellow Certificate of The Royal College of Physician and Surgeon of Canada. June 1990 had a Clinical Fellowship in Pediatric Hematology/Oncology Sick Kid Hospital, Toronto University Canada. Maintenance Certificate 2005. Yearly participate in International & Local Conferences with more than 280 research and 86 publications. Dr. Jaouni is well known for her dedication active role in research on hereditary blood disease, cancer research and natural products research. Lately more interest in the quality of life and supportive care. She have an active role in public education to minimized and control inherited blood diseases, environmental pollution and cancer prevention.

Oncology, Hematology

Professor Douaa Mohammed Sayed hold her Master and M.D. in Clinical Pathology from Faculty of Medicine and South Egypt Cancer Institute Assiut University, Egypt. She is a Vice dean of postgraduate and research and director of Flow cytometry lab in South Egypt Cancer Institute which is the first flow cytometry lab accredited by ISO15189 in the middle East. She is also an Executive manager for the first Bone Marrow Transplantation centre and biorepresitory units in South Egypt. She hold the Incentive (Encouraging) National Award in Medicine Science 2011 and award for best research in Medical laboratory and hematology 2013, from Academy of Scientific Research and Technology, Egypt. She also act as assister editor for SECI Oncology journal and reviewer in more than 6 other peer-reviewed international journals and published more than 60 papers in peer-reviewed high impact factor international journals within the field of interest.

Clinical Pathology, Flow Cytometry, Bone Marrow Transplantation